Still too soon, U.S. says of Pfizer's 3rd-shot push
Representatives for Pfizer met privately with senior U.S. scientists and regulators Monday to press their case for swift authorization of coronavirus booster vaccines, amid growing…
Representatives for Pfizer met privately with senior U.S. scientists and regulators Monday to press their case for swift authorization of coronavirus booster vaccines, amid growing…